<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940106-1-00023</title>
	</head>
	<body>
		<main>
			<p><!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Comments will be considered if we receive them at the appropriate address, as provided below, no later than 5 p.m. on March 7, 1994.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> <!-- PJG STAG 4702 -->  <!-- PJG ITAG l=94 g=1 f=2 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=2 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=2 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=2 -->  <USBUREAU>Health Care Financing Administration</USBUREAU> <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=52 g=1 f=2 -->  <CFRNO>42 CFR Part 406 </CFRNO> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=41 g=1 f=2 -->  <RINDOCK>[BPD&hyph;738&hyph;P] </RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=91 g=1 f=2 -->  <RINDOCK>RIN: 0938&hyph;AG19 </RINDOCK> <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=56 g=1 f=2 --> Medicare Program; Revisions to the Definition of End-Stage Renal Disease and Resumption of Entitlement  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <AGENCY> <!-- PJG ITAG l=10 g=1 f=2 --> AGENCY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Health Care Financing Administration (HCFA), HHS.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </AGENCY> <ACTION> <!-- PJG ITAG l=10 g=1 f=2 --> ACTION: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Proposed rule.  <!-- PJG /ITAG -->  <!-- PJG ITAG l=59 g=1 f=1 -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </ACTION> <SUMMARY> <!-- PJG ITAG l=10 g=1 f=2 --> SUMMARY: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  We propose to revise the definition of end-stage renal disease to reflect that more than one dialysis treatment is required for there to be a ``regular course of dialysis'' and to require that generally accepted diagnostic criteria and laboratory findings must form the basis of the physician's certification of end-stage renal disease. The purpose of this proposed revision is to eliminate any misinterpretation of the definition of end-stage renal disease. We propose to do so by clarifying that only those individuals whose kidneys have failed and for whom the disease is expected to be a lifelong affliction are eligible for Medicare end-stage renal disease benefits.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> We also propose to amend the regulations to specify that Medicare entitlement is resumed for individuals who again begin a regular course of renal dialysis treatments after a previous course is terminated (with or without a transplant), and to add the same considerations for those who have a second transplant. Therefore, the purpose of these proposed revisions is to conform the regulations more closely to the intent of sections 226A (c)(2) and (c)(3) of the Social Security Act regarding resumption of entitlement to Medicare.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </SUMMARY> <DATE> <!-- PJG ITAG l=10 g=1 f=2 --> DATES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Comments will be considered if we receive them at the appropriate address, as provided below, no later than 5 p.m. on March 7, 1994.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline --> </DATE> <ADDRESS> <!-- PJG ITAG l=10 g=1 f=2 --> ADDRESSES: <!-- PJG /ITAG -->  <!-- PJG ITAG l=10 g=1 f=1 -->  Mail comments to the following address:  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=15 g=1 f=1 --> Health Care Financing Administration, Department of Health and Human Services, Attention: BPD&hyph;738&hyph;P, P.O. Box 26676, Baltimore, MD 21207.  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> If you prefer, you may deliver your written comments to one of the following addresses:  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=15 g=1 f=1 --> Room 309&hyph;G, Hubert H. Humphrey Building, 200 Independence Avenue, SW., Washington, DC. 20201, or <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=15 g=1 f=1 --> Room 132, East High Rise Building, 6325 Security Boulevard, Baltimore, Maryland 21207. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->   <!-- PJG 0012 frnewline --> </ADDRESS> <!-- PJG /STAG --></p>
		</main>
</body></html>
            